- Home
- JVA vs RLMD Comparison
JVA vs RLMD Comparison
Compare JVA & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JVA
- RLMD
- Stock Information
- Founded
- JVA 1971
- RLMD 2004
- Country
- JVA United States
- RLMD United States
- Employees
- JVA N/A
- RLMD N/A
- Industry
- JVA Packaged Foods
- RLMD Biotechnology: Pharmaceutical Preparations
- Sector
- JVA Consumer Staples
- RLMD Health Care
- Exchange
- JVA Nasdaq
- RLMD Nasdaq
- Market Cap
- JVA 24.7M
- RLMD 22.0M
- IPO Year
- JVA 2005
- RLMD N/A
- Fundamental
- Price
- JVA $4.50
- RLMD $0.61
- Analyst Decision
- JVA
- RLMD Buy
- Analyst Count
- JVA 0
- RLMD 3
- Target Price
- JVA N/A
- RLMD $5.00
- AVG Volume (30 Days)
- JVA 227.0K
- RLMD 338.9K
- Earning Date
- JVA 06-13-2025
- RLMD 08-06-2025
- Dividend Yield
- JVA N/A
- RLMD N/A
- EPS Growth
- JVA 856.08
- RLMD N/A
- EPS
- JVA 0.65
- RLMD N/A
- Revenue
- JVA $84,651,329.00
- RLMD N/A
- Revenue This Year
- JVA N/A
- RLMD N/A
- Revenue Next Year
- JVA N/A
- RLMD N/A
- P/E Ratio
- JVA $6.97
- RLMD N/A
- Revenue Growth
- JVA 15.86
- RLMD N/A
- 52 Week Low
- JVA $1.50
- RLMD $0.24
- 52 Week High
- JVA $9.93
- RLMD $4.47
- Technical
- Relative Strength Index (RSI)
- JVA 57.42
- RLMD 47.74
- Support Level
- JVA $4.15
- RLMD $0.60
- Resistance Level
- JVA $4.54
- RLMD $0.69
- Average True Range (ATR)
- JVA 0.28
- RLMD 0.07
- MACD
- JVA -0.01
- RLMD -0.01
- Stochastic Oscillator
- JVA 61.54
- RLMD 41.86
About JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.